Establish presence or absence of active disease.
Consider a patient as infectious if they have a positive sputum sample of for acid-fast bacilli and/or within the first 3 weeks of starting therapy for active TB.
Patients with 3 negative sputum samples collected within 24 hours is considered non-infectious.
Patients with active pulmonary or laryngeal disease: only perform emergency dental care. Avoid aerosol-generating procedures.
Patients with non-active pulmonary or laryngeal disease (history of TB or with a positive PPD but without signs and symptoms): no contraindications for dental care.
Refer patients with signs and symptoms of TB to a physician for evaluation.
Be aware of reduced efficacy of ketoconazole, fluconazole, diazepam, and glucocorticosteroids in patients taking rifampin.
⚠️ Avoid acetaminophen-containing medication for patients taking rifampin as this combination of medications may increase liver toxicity.
Tuberculosis MCS1C Anticipated
Hemostasis None Microbial
None Drugs/ drug
Major Stress/trauma None
See Medical Complexity Status for more information.
- Medical Disorders
- Tuberculosis. MedlinePlus. U.S. National Library of Medicine. May 21, 2021.
- Latent TB Infection and TB Disease. Centers for Disease Control and Prevention. December 11, 2020.
- Testing for TB Infection. Centers for Disease Control and Prevention. March 8, 2021.
- BCG Vaccine. Centers for Disease Control and Prevention. May 4, 2016.
- Drug-Resistant TB. Centers for Disease Control and Prevention. January 17, 2017.